Related Experiment Video

Updated: Aug 27, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.6K

A case of protracted eosinopenia after a single subcutaneous dose of benralizumab

Joana Miranda1,2, José Luís Plácido1, Luís Amaral1

  • 1Serviço de Imunoalergologia, Centro Hospitalar Universitário de São João E.P.E, Porto, Portugal.

Allergo Journal International
|October 3, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Anti-IL5 therapyCase reportEosinophilEosinophilic asthmaSevere asthma

More Related Videos

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

881
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge08:38

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge

Published on: April 9, 2012

20.5K

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
405
Allergic Reactions02:06

Allergic Reactions

Overview
28.2K